
    
      This is a prospective, multi-centre, cluster randomized, open label, parallel controlled
      study that enrolled patients with acute ischemic stroke who underwent endovascular treatment
      in about 34 hospitals in China. The ratio Interventional arm control arm is 1:1, which means
      17 hospitals and 332 participants in each arm.
    
  